Bone Mineral Density After Transitioning From Denosumab to Alendronate
Bone Mineral Density After Transitioning From Denosumab to Alendronate
About this item
Full title
Author / Creator
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
Context
There are few studies on patients transitioning from denosumab to bisphosphonates.
Objective
To investigate patient characteristics and changes in bone mineral density (BMD) after transitioning from denosumab to alendronate.
Design
Randomized, open-label, 2-year crossover Denosumab Adherence Preference Satisfactio...
Alternative Titles
Full title
Bone Mineral Density After Transitioning From Denosumab to Alendronate
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7112973
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7112973
Other Identifiers
ISSN
0021-972X
E-ISSN
1945-7197
DOI
10.1210/clinem/dgz095
